Sodium hydrosulfide influences ovarian steroid production in PCOS model

Overview

This study investigates the effects of sodium hydrosulfide (NaHS) on ovarian steroidogenesis and follicle health in a rat model of polycystic ovary syndrome (PCOS) induced by dehydroepiandrosterone (DHEA). NaHS administration improved estrous cyclicity, reduced follicular damage, and modulated the expression of steroidogenic enzymes.

Background

Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, characterized by hormonal imbalances and ovarian dysfunction. Understanding the underlying mechanisms and potential therapeutic interventions is crucial for managing PCOS effectively. Hydrogen sulfide (H2S) has emerged as a potential regulator of ovarian physiology, yet its specific role in PCOS remains to be fully elucidated.

Data Highlights

Key Findings

• DHEA treatment disrupted estrous cyclicity and elevated serum estradiol and progesterone levels.
• NaHS administration improved estrous cyclicity and reduced follicular damage and apoptosis.
• Expression of steroidogenic enzymes (StAR, 3β-HSD, CYP19A1) was significantly elevated in the PCOS group.
• NaHS partially restored the expression of H2S-producing enzymes (CBS, CTH).
• Follicular health was negatively impacted by DHEA, leading to increased cystic and atretic follicles.

Clinical Implications

Further research is warranted to explore the mechanisms by which H2S influences ovarian physiology.

Conclusion

Sodium hydrosulfide modulates steroidogenic enzyme expression and improves follicular health in a rat model of PCOS.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Clinical Rheumatology — Assessment of Ovarian Reserve in Women Diagnosed with Sjögren’s Syndrome: A Cross-Sectional Analysis
3. Archives of Toxicology — Calretinin Emerges as a Potential Biomarker for Negative Ovarian Outcomes Linked to Early Life Exposure to Endocrine Disruptor Mixtures in Rats
4. Archives of Toxicology — Gene Expression Analysis of Developing Rat Ovaries After In-Utero Exposure to Endocrine Disruptors Diethylstilbestrol and Ketoconazole
5. Frontiers in Endocrinology — IGF-II, IGFBP-4, -6, and -7, and HMGB1 show changes in follicular fluid in PCOS
6. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
7. Polycystic Ovary Syndrome: Assessment and Management Guidelines | AAFP
8. https://academic.oup.com/ejendo/article/194/3/S25/8488941
9. Effectiveness of GLP-1 Receptor Agonists in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials - PubMed
10. Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials | Scientific Reports
11. Effects of GLP-1 Receptor Agonists vs Metformin in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis - PubMed
12. Exploring the Therapeutic Potential of Sodium Hydrosulfide in Alleviating Oxidative Stress and Ovarian Dysfunction in a Rat Model of Polycystic Ovary Syndrome - PMC
13. Exploring the Therapeutic Potential of Sodium Hydrosulfide in Alleviating Oxidative Stress and Ovarian Dysfunction in a Rat Model of Polycystic Ovary Syndrome - PubMed
14. The likely role of hydrogen sulfide-mediated regulation of pyroptosis in polycystic ovaries - PubMed